PHASE 2A STUDY OF ALXN1007, A NOVEL C5A INHIBITOR, IN SUBJECTS WITH NEWLY DIAGNOSED ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) INVOLVING THE LOWER GASTROINTESTINAL TRACT
EHA Library, Amin Majid Alousi,
135380
L-ARGININE SUPPLEMENTATION DECREASES HEMOLYSIS AND PULMONARY ARTERIAL HYPERTENSION IN SICKLE CELL DISEASE PATIENTS: A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL.
EHA Library, Joao Ricardo Friedrisch,
135378
ALXN1210, A LONG-ACTING C5 INHIBITOR, RESULTS IN RAPID AND SUSTAINED REDUCTION OF LDH WITH A MONTHLY DOSING INTERVAL IN PATIENTS WITH PNH: PRELIMINARY DATA FROM A DOSE-ESCALATION STUDY
EHA Library, Jong Wook Lee,
135358